Prof. Dr. phil. nat. Katharina Lückerath
Professor Preclinical Theranostics
Katharina is a biomedical scientist with a focus on experimental and translational theranostics. She is interested in understanding mechanisms underlying failure of radioligand therapy, and aims at improving theranostic approaches and thus, outcomes for cancer patients. Katharina obtained her PhD at the Institute for Tumor Biology and Experimental Therapy (Georg-Speyer-Haus, Germany). She served as head of the research group Experimental Oncology in Nuclear Medicine at the University of Würzurg (Germany), and of the pre-clinical Nuclear Medicine team at the University of California Los Angeles (USA), before transferring to University Hospital Essen in March 2021.